BIOCRYST PHARMACEUTICALS INC Insider Trading for November 2018
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in BIOCRYST PHARMACEUTICALS INC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in BIOCRYST PHARMACEUTICALS INC for November 2018.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Nov 30 2018 | BCRX | BIOCRYST PHARMACEU ... | Erck Stanley C | Director | Option Exercise | M | 1.49 | 8,333 | 12,416 | 0 | |
| Nov 30 2018 | BCRX | BIOCRYST PHARMACEU ... | Erck Stanley C | Director | Buy | M | 1.49 | 8,333 | 12,416 | 48,333 | 40 K to 48.3 K (+20.83 %) |
| Nov 26 2018 | BCRX | BIOCRYST PHARMACEU ... | Powell Lynne | Senior VP - CCO | Option Exercise | M | 3.22 | 12,000 | 38,640 | 101,427 | |
| Nov 26 2018 | BCRX | BIOCRYST PHARMACEU ... | Powell Lynne | Senior VP - CCO | Sell | S | 9.01 | 2,455 | 22,120 | 0 | 2.5 K to 0 (-100.00 %) |
| Nov 26 2018 | BCRX | BIOCRYST PHARMACEU ... | Powell Lynne | Senior VP - CCO | Sell | S | 9.06 | 12,000 | 108,720 | 2,455 | 14.5 K to 2.5 K (-83.02 %) |
| Nov 26 2018 | BCRX | BIOCRYST PHARMACEU ... | Powell Lynne | Senior VP - CCO | Buy | M | 3.22 | 12,000 | 38,640 | 14,455 | 2.5 K to 14.5 K (+488.80 %) |
| Nov 26 2018 | BCRX | BIOCRYST PHARMACEU ... | STAAB THOMAS R II | Senior Vice Preside ... | Option Exercise | M | 3.78 | 3,500 | 13,230 | 28,305 | |
| Nov 26 2018 | BCRX | BIOCRYST PHARMACEU ... | STAAB THOMAS R II | Senior Vice Preside ... | Option Exercise | M | 3.78 | 7,000 | 26,460 | 31,805 | |
| Nov 26 2018 | BCRX | BIOCRYST PHARMACEU ... | STAAB THOMAS R II | Senior Vice Preside ... | Option Exercise | M | 5.45 | 5,000 | 27,250 | 12,000 | |
| Nov 26 2018 | BCRX | BIOCRYST PHARMACEU ... | STAAB THOMAS R II | Senior Vice Preside ... | Sell | S | 9.66 | 3,500 | 33,810 | 137,383 | 140.9 K to 137.4 K (-2.48 %) |
| Nov 26 2018 | BCRX | BIOCRYST PHARMACEU ... | STAAB THOMAS R II | Senior Vice Preside ... | Buy | M | 3.78 | 3,500 | 13,230 | 140,883 | 137.4 K to 140.9 K (+2.55 %) |
| Nov 26 2018 | BCRX | BIOCRYST PHARMACEU ... | STAAB THOMAS R II | Senior Vice Preside ... | Sell | S | 9.08 | 7,000 | 63,560 | 137,383 | 144.4 K to 137.4 K (-4.85 %) |
| Nov 26 2018 | BCRX | BIOCRYST PHARMACEU ... | STAAB THOMAS R II | Senior Vice Preside ... | Buy | M | 3.78 | 7,000 | 26,460 | 144,383 | 137.4 K to 144.4 K (+5.10 %) |
| Nov 26 2018 | BCRX | BIOCRYST PHARMACEU ... | STAAB THOMAS R II | Senior Vice Preside ... | Sell | S | 9.41 | 5,000 | 47,050 | 137,383 | 142.4 K to 137.4 K (-3.51 %) |
| Nov 26 2018 | BCRX | BIOCRYST PHARMACEU ... | STAAB THOMAS R II | Senior Vice Preside ... | Buy | M | 5.45 | 5,000 | 27,250 | 142,383 | 137.4 K to 142.4 K (+3.64 %) |
| Nov 21 2018 | BCRX | BIOCRYST PHARMACEU ... | Powell Lynne | Senior VP - CCO | Option Exercise | M | 3.22 | 9,127 | 29,389 | 113,427 | |
| Nov 21 2018 | BCRX | BIOCRYST PHARMACEU ... | Powell Lynne | Senior VP - CCO | Option Exercise | M | 3.22 | 9,127 | 29,389 | 113,427 | |
| Nov 21 2018 | BCRX | BIOCRYST PHARMACEU ... | Powell Lynne | Senior VP - CCO | Option Exercise | M | 3.22 | 193 | 621 | 122,554 | |
| Nov 21 2018 | BCRX | BIOCRYST PHARMACEU ... | Powell Lynne | Senior VP - CCO | Option Exercise | M | 3.22 | 193 | 621 | 122,554 | |
| Nov 21 2018 | BCRX | BIOCRYST PHARMACEU ... | Powell Lynne | Senior VP - CCO | Sell | S | 8.61 | 6,150 | 52,952 | 2,455 | 8.6 K to 2.5 K (-71.47 %) |
| Nov 21 2018 | BCRX | BIOCRYST PHARMACEU ... | Powell Lynne | Senior VP - CCO | Sell | S | 8.61 | 6,150 | 52,952 | 2,455 | 8.6 K to 2.5 K (-71.47 %) |
| Nov 21 2018 | BCRX | BIOCRYST PHARMACEU ... | Powell Lynne | Senior VP - CCO | Sell | S | 8.52 | 9,127 | 77,762 | 8,605 | 17.7 K to 8.6 K (-51.47 %) |
| Nov 21 2018 | BCRX | BIOCRYST PHARMACEU ... | Powell Lynne | Senior VP - CCO | Sell | S | 8.52 | 9,127 | 77,762 | 8,605 | 17.7 K to 8.6 K (-51.47 %) |
| Nov 21 2018 | BCRX | BIOCRYST PHARMACEU ... | Powell Lynne | Senior VP - CCO | Buy | M | 3.22 | 9,127 | 29,389 | 17,732 | 8.6 K to 17.7 K (+106.07 %) |
| Nov 21 2018 | BCRX | BIOCRYST PHARMACEU ... | Powell Lynne | Senior VP - CCO | Buy | M | 3.22 | 9,127 | 29,389 | 17,732 | 8.6 K to 17.7 K (+106.07 %) |
| Nov 21 2018 | BCRX | BIOCRYST PHARMACEU ... | Powell Lynne | Senior VP - CCO | Sell | S | 8.30 | 193 | 1,602 | 8,605 | 8.8 K to 8.6 K (-2.19 %) |
| Nov 21 2018 | BCRX | BIOCRYST PHARMACEU ... | Powell Lynne | Senior VP - CCO | Sell | S | 8.30 | 193 | 1,602 | 8,605 | 8.8 K to 8.6 K (-2.19 %) |
| Nov 21 2018 | BCRX | BIOCRYST PHARMACEU ... | Powell Lynne | Senior VP - CCO | Buy | M | 3.22 | 193 | 621 | 8,798 | 8.6 K to 8.8 K (+2.24 %) |
| Nov 21 2018 | BCRX | BIOCRYST PHARMACEU ... | Powell Lynne | Senior VP - CCO | Buy | M | 3.22 | 193 | 621 | 8,798 | 8.6 K to 8.8 K (+2.24 %) |
| Nov 21 2018 | BCRX | BIOCRYST PHARMACEU ... | STAAB THOMAS R II | Senior Vice Preside ... | Option Exercise | M | 3.22 | 6,500 | 20,930 | 97,071 | |
| Nov 21 2018 | BCRX | BIOCRYST PHARMACEU ... | STAAB THOMAS R II | Senior Vice Preside ... | Option Exercise | M | 3.22 | 6,500 | 20,930 | 97,071 | |
| Nov 21 2018 | BCRX | BIOCRYST PHARMACEU ... | STAAB THOMAS R II | Senior Vice Preside ... | Option Exercise | M | 3.78 | 4,623 | 17,475 | 38,805 | |
| Nov 21 2018 | BCRX | BIOCRYST PHARMACEU ... | STAAB THOMAS R II | Senior Vice Preside ... | Option Exercise | M | 3.78 | 4,623 | 17,475 | 38,805 | |
| Nov 21 2018 | BCRX | BIOCRYST PHARMACEU ... | STAAB THOMAS R II | Senior Vice Preside ... | Option Exercise | M | 3.78 | 75 | 284 | 43,428 | |
| Nov 21 2018 | BCRX | BIOCRYST PHARMACEU ... | STAAB THOMAS R II | Senior Vice Preside ... | Option Exercise | M | 3.78 | 75 | 284 | 43,428 | |
| Nov 21 2018 | BCRX | BIOCRYST PHARMACEU ... | STAAB THOMAS R II | Senior Vice Preside ... | Sell | S | 8.75 | 6,500 | 56,875 | 137,383 | 143.9 K to 137.4 K (-4.52 %) |
| Nov 21 2018 | BCRX | BIOCRYST PHARMACEU ... | STAAB THOMAS R II | Senior Vice Preside ... | Sell | S | 8.75 | 6,500 | 56,875 | 137,383 | 143.9 K to 137.4 K (-4.52 %) |
| Nov 21 2018 | BCRX | BIOCRYST PHARMACEU ... | STAAB THOMAS R II | Senior Vice Preside ... | Buy | M | 3.22 | 6,500 | 20,930 | 143,883 | 137.4 K to 143.9 K (+4.73 %) |
| Nov 21 2018 | BCRX | BIOCRYST PHARMACEU ... | STAAB THOMAS R II | Senior Vice Preside ... | Buy | M | 3.22 | 6,500 | 20,930 | 143,883 | 137.4 K to 143.9 K (+4.73 %) |
| Nov 21 2018 | BCRX | BIOCRYST PHARMACEU ... | STAAB THOMAS R II | Senior Vice Preside ... | Sell | S | 8.57 | 4,623 | 39,619 | 137,383 | 142 K to 137.4 K (-3.26 %) |
| Nov 21 2018 | BCRX | BIOCRYST PHARMACEU ... | STAAB THOMAS R II | Senior Vice Preside ... | Sell | S | 8.57 | 4,623 | 39,619 | 137,383 | 142 K to 137.4 K (-3.26 %) |
| Nov 21 2018 | BCRX | BIOCRYST PHARMACEU ... | STAAB THOMAS R II | Senior Vice Preside ... | Buy | M | 3.78 | 4,623 | 17,475 | 142,006 | 137.4 K to 142 K (+3.37 %) |
| Nov 21 2018 | BCRX | BIOCRYST PHARMACEU ... | STAAB THOMAS R II | Senior Vice Preside ... | Buy | M | 3.78 | 4,623 | 17,475 | 142,006 | 137.4 K to 142 K (+3.37 %) |
| Nov 21 2018 | BCRX | BIOCRYST PHARMACEU ... | STAAB THOMAS R II | Senior Vice Preside ... | Sell | S | 8.30 | 75 | 623 | 137,383 | 137.5 K to 137.4 K (-0.05 %) |
| Nov 21 2018 | BCRX | BIOCRYST PHARMACEU ... | STAAB THOMAS R II | Senior Vice Preside ... | Sell | S | 8.30 | 75 | 623 | 137,383 | 137.5 K to 137.4 K (-0.05 %) |
| Nov 21 2018 | BCRX | BIOCRYST PHARMACEU ... | STAAB THOMAS R II | Senior Vice Preside ... | Buy | M | 3.78 | 75 | 284 | 137,458 | 137.4 K to 137.5 K (+0.05 %) |
| Nov 21 2018 | BCRX | BIOCRYST PHARMACEU ... | STAAB THOMAS R II | Senior Vice Preside ... | Buy | M | 3.78 | 75 | 284 | 137,458 | 137.4 K to 137.5 K (+0.05 %) |
| Nov 09 2018 | BCRX | BIOCRYST PHARMACEU ... | STAAB THOMAS R II | Senior Vice Preside ... | Option Exercise | M | 3.78 | 2,302 | 8,702 | 43,503 | |
| Nov 09 2018 | BCRX | BIOCRYST PHARMACEU ... | STAAB THOMAS R II | Senior Vice Preside ... | Option Exercise | M | 3.22 | 11,113 | 35,784 | 103,571 | |
| Nov 09 2018 | BCRX | BIOCRYST PHARMACEU ... | STAAB THOMAS R II | Senior Vice Preside ... | Option Exercise | M | 3.22 | 672 | 2,164 | 114,684 | |
| Nov 09 2018 | BCRX | BIOCRYST PHARMACEU ... | STAAB THOMAS R II | Senior Vice Preside ... | Sell | S | 8.30 | 2,302 | 19,107 | 137,383 | 139.7 K to 137.4 K (-1.65 %) |
| Nov 09 2018 | BCRX | BIOCRYST PHARMACEU ... | STAAB THOMAS R II | Senior Vice Preside ... | Buy | M | 3.78 | 2,302 | 8,702 | 139,685 | 137.4 K to 139.7 K (+1.68 %) |
| Nov 09 2018 | BCRX | BIOCRYST PHARMACEU ... | STAAB THOMAS R II | Senior Vice Preside ... | Sell | S | 8.09 | 11,113 | 89,904 | 137,383 | 148.5 K to 137.4 K (-7.48 %) |
| Nov 09 2018 | BCRX | BIOCRYST PHARMACEU ... | STAAB THOMAS R II | Senior Vice Preside ... | Buy | M | 3.22 | 11,113 | 35,784 | 148,496 | 137.4 K to 148.5 K (+8.09 %) |
| Nov 09 2018 | BCRX | BIOCRYST PHARMACEU ... | STAAB THOMAS R II | Senior Vice Preside ... | Sell | S | 8.00 | 672 | 5,376 | 137,383 | 138.1 K to 137.4 K (-0.49 %) |
| Nov 09 2018 | BCRX | BIOCRYST PHARMACEU ... | STAAB THOMAS R II | Senior Vice Preside ... | Buy | M | 3.22 | 672 | 2,164 | 138,055 | 137.4 K to 138.1 K (+0.49 %) |
| Nov 09 2018 | BCRX | BIOCRYST PHARMACEU ... | Powell Lynne | Senior VP - CCO | Option Exercise | M | 3.22 | 5,280 | 17,002 | 122,747 | |
| Nov 09 2018 | BCRX | BIOCRYST PHARMACEU ... | Powell Lynne | Senior VP - CCO | Option Exercise | M | 3.22 | 300 | 966 | 128,027 | |
| Nov 09 2018 | BCRX | BIOCRYST PHARMACEU ... | Powell Lynne | Senior VP - CCO | Sell | S | 8.15 | 5,280 | 43,032 | 8,605 | 13.9 K to 8.6 K (-38.03 %) |
| Nov 09 2018 | BCRX | BIOCRYST PHARMACEU ... | Powell Lynne | Senior VP - CCO | Buy | M | 3.22 | 5,280 | 17,002 | 13,885 | 8.6 K to 13.9 K (+61.36 %) |
| Nov 09 2018 | BCRX | BIOCRYST PHARMACEU ... | Powell Lynne | Senior VP - CCO | Sell | S | 8.00 | 300 | 2,400 | 8,605 | 8.9 K to 8.6 K (-3.37 %) |
| Nov 09 2018 | BCRX | BIOCRYST PHARMACEU ... | Powell Lynne | Senior VP - CCO | Buy | M | 3.22 | 300 | 966 | 8,905 | 8.6 K to 8.9 K (+3.49 %) |
| Nov 07 2018 | BCRX | BIOCRYST PHARMACEU ... | Powell Lynne | Senior VP - CCO | Option Exercise | M | 3.22 | 100 | 322 | 128,327 | |
| Nov 07 2018 | BCRX | BIOCRYST PHARMACEU ... | Powell Lynne | Senior VP - CCO | Sell | S | 8.00 | 100 | 800 | 8,605 | 8.7 K to 8.6 K (-1.15 %) |
| Nov 07 2018 | BCRX | BIOCRYST PHARMACEU ... | Powell Lynne | Senior VP - CCO | Buy | M | 3.22 | 100 | 322 | 8,705 | 8.6 K to 8.7 K (+1.16 %) |
| Nov 07 2018 | BCRX | BIOCRYST PHARMACEU ... | STAAB THOMAS R II | Senior Vice Preside ... | Option Exercise | M | 3.22 | 215 | 692 | 115,356 | |
| Nov 07 2018 | BCRX | BIOCRYST PHARMACEU ... | STAAB THOMAS R II | Senior Vice Preside ... | Sell | S | 8.00 | 215 | 1,720 | 137,383 | 137.6 K to 137.4 K (-0.16 %) |
| Nov 07 2018 | BCRX | BIOCRYST PHARMACEU ... | STAAB THOMAS R II | Senior Vice Preside ... | Buy | M | 3.22 | 215 | 692 | 137,598 | 137.4 K to 137.6 K (+0.16 %) |
| Nov 06 2018 | BCRX | BIOCRYST PHARMACEU ... | Powell Lynne | Senior VP - CCO | Option Exercise | M | 3.22 | 1,000 | 3,220 | 128,427 | |
| Nov 06 2018 | BCRX | BIOCRYST PHARMACEU ... | Powell Lynne | Senior VP - CCO | Sell | S | 8.00 | 1,000 | 8,000 | 8,605 | 9.6 K to 8.6 K (-10.41 %) |
| Nov 06 2018 | BCRX | BIOCRYST PHARMACEU ... | Powell Lynne | Senior VP - CCO | Buy | M | 3.22 | 1,000 | 3,220 | 9,605 | 8.6 K to 9.6 K (+11.62 %) |
| Nov 06 2018 | BCRX | BIOCRYST PHARMACEU ... | STAAB THOMAS R II | Senior Vice Preside ... | Option Exercise | M | 3.78 | 3,500 | 13,230 | 45,805 | |
| Nov 06 2018 | BCRX | BIOCRYST PHARMACEU ... | STAAB THOMAS R II | Senior Vice Preside ... | Option Exercise | M | 3.22 | 7,356 | 23,686 | 115,571 | |
| Nov 06 2018 | BCRX | BIOCRYST PHARMACEU ... | STAAB THOMAS R II | Senior Vice Preside ... | Sell | S | 7.96 | 3,500 | 27,860 | 137,383 | 140.9 K to 137.4 K (-2.48 %) |
| Nov 06 2018 | BCRX | BIOCRYST PHARMACEU ... | STAAB THOMAS R II | Senior Vice Preside ... | Buy | M | 3.78 | 3,500 | 13,230 | 140,883 | 137.4 K to 140.9 K (+2.55 %) |
| Nov 06 2018 | BCRX | BIOCRYST PHARMACEU ... | STAAB THOMAS R II | Senior Vice Preside ... | Sell | S | 7.78 | 7,356 | 57,230 | 137,383 | 144.7 K to 137.4 K (-5.08 %) |
| Nov 06 2018 | BCRX | BIOCRYST PHARMACEU ... | STAAB THOMAS R II | Senior Vice Preside ... | Buy | M | 3.22 | 7,356 | 23,686 | 144,739 | 137.4 K to 144.7 K (+5.35 %) |
| Nov 05 2018 | BCRX | BIOCRYST PHARMACEU ... | Powell Lynne | Senior VP - CCO | Sell | S | 7.51 | 1,544 | 11,595 | 8,605 | 10.1 K to 8.6 K (-15.21 %) |